Retrospective review analysis of COVID-19 patients co-infected with Mycoplasma pneumoniae

Conclusion: Our confirmed the presence of co-infection with M. pneumoniae and describes the clinical features, investigation results, clinical course, and outcomes for these patients. Further research is needed to review the role of procalcitonin in excluding bacterial co-infection and to assess the impact of co-infection of patients with COVID-19 on morbidity and mortality.

Source: Lung India - March 6, 2021 Category: Respiratory Medicine Authors: Abhinav Choubey Diaeddin Sagar Philippa Cawley Katherine Miller Source Type: research